View this email in your browser

June 2017

Important New Products

• Onivyde (nanoliposomal irinotecan as sucrosofate) is a topoisomerase inhibitor ...(more)
• Ristempa (pegfilgrastim (rbe)) is a long-acting form of recombinant human granulocyte ...(more)

New Indications

• Fycompa (perampanel (as hemisesquihydrate)) is now indicated for the adjunctive ...(more)
• INOmax (nitric oxide for inhalation), in conjunction with ventilatory support and ...(more)
• Kalydeco (ivacaftor) is now indicated for the treatment of cystic fibrosis (CF) in ...(more)

New Contraindications

• Accupril (quinapril hydrochloride) and Accuretic (quinapril hydrochloride/ ...(more)
• Angiomax (bivalirudin) is now contraindicated in severe renal impairment ...(more)
• DBL Amikacin Injection (amikacin sulfate) is now contraindicated in myasthenia gravis ...(more)
• DBL Sulfamethoxazole 400 mg and Trimethoprim 80 mg Concentrate Injection BP ...(more)
• Diane-35 ED, Juliet-35 ED (cyproterone acetate/ethinylestradiol) Petibelle, Yasmin, ...(more)
• Indocid (indometacin) is now contraindicated in severe hepatic impairment. ...(more)
• Prezista (darunavir) is now contraindicated with elbasvir/grazoprevir and lurasidone. ...(more)
• Stelazine (trifluoperazine hydrochloride) is now contraindicated in uncontrolled ...(more)
• Xifaxan 550 mg (rifaximin) is now contraindicated with intestinal obstruction. ...(more)

To contact MIMS editorial please email editorial@mims.com.au. To enquire about purchasing a product please contact MIMS Customer service on 1800 800 629 or email subscriptions@mims.com.au. For more information about MIMS, please see www.mims.com.au

Copyright © 2017 MIMS Australia Pty Ltd. All rights reserved.
Our mailing address is:
MIMS Australia, Level 2, 1 Chandos Street, St Leonards NSW 2065, Phone: 1800 800 629

Unsubscribe | Privacy